Biblio

Author Title Type [ Year(Asc)]
Filters: Author is Han, Li  [Clear All Filters]
2024
Chen X, Fan K, Lu J, Zhang S, Dong J, Qin J, Fan W, Wang Y, Zhang Y, Peng H, et al. Selecting Monoclonal Cell Lineages from Somatic Reprogramming Using Robotic-Based Spatial-Restricting Structured Flow. Research (Wash D C). 2024;7:0338.
Zhao Z, Han L, Xin M, Zhou L, Jiang K, Huang Q, Dai R. Still water run deep: Therapeutic TP effect of ucMSC-Ex via regulating mTOR to enhance autophagy. J Cell Mol Med. 2024;28(4):e18120.
2023
Zhang Y, Liu FA, Liang XL, Zhu J, Han L, Shi XD, Cao J, Li Z, Chen W, Xu K, et al. Expression and prognostic value of C-reactive protein in adult immune thrombocytopenia (ITP) patients. Clin Exp Med. 2023.
Chen Z, Zhou K, Xue J, Small A, Xiao G, Nguyen LXuan Truon, Zhang Z, Prince E, Weng H, Huang H, et al. Phosphorylation stabilized TET1 acts as an oncoprotein and therapeutic target in B cell acute lymphoblastic leukemia. Sci Transl Med. 2023;15(689):eabq8513.
Zhao Z, Qing Y, Dong L, Han L, Wu D, Li Y, Li W, Xue J, Zhou K, Sun M, et al. QKI shuttles internal mG-modified transcripts into stress granules and modulates mRNA metabolism. Cell. 2023.
Zhang X, Zhang Y, Liu FA, Zhu J, Liang XL, Shi XD, Han L, Xu K, Cheng H. Red blood cell distribution width as a prognostic factor in patients with aplastic anemia treated with cyclosporin A plus androgen or cyclosporine A alone: a retrospective study. Hematology. 2023;28(1):2240665.
2022
Weng H, Huang F, Yu Z, Chen Z, Prince E, Kang Y, Zhou K, Li W, Hu J, Fu C, et al. The mA reader IGF2BP2 regulates glutamine metabolism and represents a therapeutic target in acute myeloid leukemia. Cancer Cell. 2022.
Ma C, Han L, Wu J, Tang F, Deng Q, He T, Wu Z, Ma C, Huang W, Huang R, et al. MSCs cell fates in murine acute liver injury and chronic liver fibrosis induced by carbon tetrachloride. Drug Metab Dispos. 2022.
2021
Qing Y, Dong L, Gao L, Li C, Li Y, Han L, Prince E, Tan B, Deng X, Wetzel C, et al. R-2-hydroxyglutarate attenuates aerobic glycolysis in leukemia by targeting the FTO/mA/PFKP/LDHB axis. Mol Cell. 2021.
2020
Wang P, Song D, Wan D, Li L, Mei W, Li X, Han L, Zhu X, Yang L, Cai Y, et al. Ginsenoside panaxatriol reverses TNBC paclitaxel resistance by inhibiting the IRAK1/NF-κB and ERK pathways. PeerJ. 2020;8:e9281.
Du G, Yu M, Xu Q, Huang Z, Huang X, Han L, Fan Y, Zhang Y, Wang R, Xu S, et al. Hypomethylation of PRDM1 is associated with recurrent pregnancy loss. J Cell Mol Med. 2020.
Su R, Dong L, Li Y, Gao M, Han L, Wunderlich M, Deng X, Li H, Huang Y, Gao L, et al. Targeting FTO Suppresses Cancer Stem Cell Maintenance and Immune Evasion. Cancer Cell. 2020.
2018
Huang Z, Du G, Huang X, Han L, Han X, Xu B, Zhang Y, Yu M, Qin Y, Xia Y, et al. The enhancer RNA lnc-SLC4A1-1 epigenetically regulates unexplained recurrent pregnancy loss (URPL) by activating CXCL8 and NF-kB pathway. EBioMedicine. 2018.
Ying X, Zhang W, Fang M, Zhang W, Wang C, Han L. miR-345-5p regulates proliferation, cell cycle, and apoptosis of acute myeloid leukemia cells by targeting AKT2. J Cell Biochem. 2018.
2016
Iyer S, Han L, Ambrogini E, Yavropoulou M, Fowlkes J, Manolagas SC, Almeida M. Deletion of FoxO1, 3 and 4 in Osteoblast Progenitors Attenuates the Loss of Cancellous Bone Mass in a Mouse Model of Type 1 Diabetes. J Bone Miner Res. 2016.